C4 THERAPEUTICS INC.
6,0400
07-ноября-24 14:59:54
15 мин. задержка
Акции
+0,0700
+1,17%
Сегодняшний диапазон
5,9300 - 6,2500
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
C4 Therapeutics Announces First Patient Dosed in CFT8919 Clinical Trial
06 ноя 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
05 ноя 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
31 окт 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
28 окт 2024 15:01:00 Источник Nasdaq GlobeNewswire
-
15 окт 2024 15:01:00 Источник Nasdaq GlobeNewswire
-
09 окт 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
30 сен 2024 15:01:00 Источник Nasdaq GlobeNewswire
-
C4 Therapeutics Announces Delivery of Second Development Candidate to Biogen
10 сен 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
08 сен 2024 17:05:00 Источник Nasdaq GlobeNewswire
-
C4 Therapeutics Appoints Veteran Biotechnology Leader Stephen Fawell, Ph.D. to Board of Directors
03 сен 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
C4 Therapeutics to Participate in Upcoming September Investor Conferences
29 авг 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
14 авг 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
01 авг 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
16 июл 2024 15:01:00 Источник Nasdaq GlobeNewswire
-
C4 Therapeutics to Participate in the Virtual UBS Targeted Protein Degradation Day
08 июл 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
C4 Therapeutics Appoints Ron Cooper as Chairman of the Board of Directors
10 июн 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
08 май 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
29 апр 2024 15:01:00 Источник Nasdaq GlobeNewswire
-
C4 Therapeutics to Participate in the Stifel 2024 Targeted Oncology Forum
09 апр 2024 06:00:00 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >